Activation of estrogen receptor β reduces blood-brain barrier breakdown following ischemic injury

Neuroscience

Volumn 235, Issue , 2013, Pages 165-173

  Shin, J A ^a   Yang, S J ^a   Jeong, S I ^a   Park, H J ^a   Choi, Y H ^a   Park, E M ^a  

^a Ewha Womans University School of Medicine   (South Korea)

Author keywords

Blood brain barrier disruption; Estrogen receptor ; Hypoxia inducible factor 1 ; Ischemic stroke; Vascular endothelial growth factor; Vasogenic edema

Indexed keywords

AQUAPORIN 4; CLAUDIN 5; DIARYLPROPIONITRILE; ESTROGEN RECEPTOR BETA; HYPOXIA INDUCIBLE FACTOR 1ALPHA; IMMUNOGLOBULIN G; OCCLUDIN; PROTEIN ZO1; TRANSCRIPTION FACTOR; VASCULOTROPIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD BRAIN BARRIER; BRAIN CORTEX; BRAIN EDEMA; BRAIN INFARCTION SIZE; CONTROLLED STUDY; CORPUS STRIATUM; EXTRAVASATION; FEMALE; HYPOXIC ISCHEMIC ENCEPHALOPATHY; MOUSE; NONHUMAN; OVARIECTOMY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; TRANSIENT ISCHEMIC ATTACK; UTERUS WEIGHT; WESTERN BLOTTING;

ACTINS; ANIMALS; AQUAPORIN 4; BLOOD-BRAIN BARRIER; BLOTTING, WESTERN; BRAIN CHEMISTRY; BRAIN EDEMA; BRAIN ISCHEMIA; CLAUDIN-5; ESTROGEN RECEPTOR BETA; FEMALE; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; IMMUNOGLOBULIN G; INFARCTION, MIDDLE CEREBRAL ARTERY; MICE; MICE, INBRED C57BL; NITRILES; OCCLUDIN; OVARIECTOMY; PROPIONATES; TIGHT JUNCTIONS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84874516309     PISSN: 03064522     EISSN: 18737544     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2013.01.031     Document Type: Article

References (50)

1. Bergeron M., Yu A.Y., Solway K.E., Semenza G.L., Sharp F.R. Induction of hypoxia-inducible factor-1 (HIF-1) and its target genes following focal ischaemia in rat brain. Eur J Neurosci 1999, 11:4159-4170.
2. Burek M., Arias-Loza P.A., Roewer N., Forster C.Y. Claudin-5 as a novel estrogen target in vascular endothelium. Arterioscler Thromb Vasc Biol 2010, 30:298-304.
3. Carswell H., Macrae I., Gallagher L., Harrop E., Horsburgh K. Neuroprotection by a selective estrogen receptor beta agonist in a mouse model of global ischemia. Am J Physiol Heart Circ Physiol 2004, 287:H1501-1504.
4. Chen C., Hu Q., Yan J., Lei J., Qin L., Shi X., Luan L., Yang L., Wang K., Han J., Nanda A., Zhou C. Multiple effects of 2ME2 and D609 on the cortical expression of HIF-1alpha and apoptotic genes in a middle cerebral artery occlusion-induced focal ischemia rat model. J Neurochem 2007, 102:1831-1841.
5. Chen C., Hu Q., Yan J., Yang X., Shi X., Lei J., Chen L., Huang H., Han J., Zhang J.H., Zhou C. Early inhibition of HIF-1alpha with small interfering RNA reduces ischemic-reperfused brain injury in rats. Neurobiol Dis 2009, 33:509-517.
6. Chen W., Jadhav V., Tang J., Zhang J.H. HIF-1alpha inhibition ameliorates neonatal brain injury in a rat pup hypoxic-ischemic model. Neurobiol Dis 2008, 31:433-441.
7. Chi O.Z., Barsoum S., Wen Y., Liu X., Weiss H.R. 17beta-estradiol prevents blood-brain barrier disruption induced by VEGF. Horm Metab Res 2004, 36:272-276.
8. Chi O.Z., Hunter C., Liu X., Weiss H.R. Effects of anti-VEGF antibody on blood-brain barrier disruption in focal cerebral ischemia. Exp Neurol 2007, 204:283-287.
9. Chi O.Z., Liu X., Weiss H.R. Effects of 17beta-estradiol on blood-brain barrier disruption during focal ischemia in rats. Horm Metab Res 2002, 34:530-534.
10. Connell B.J., Saleh T.M. Differential neuroprotection of selective estrogen receptor agonists against autonomic dysfunction and ischemic cell death in permanent versus reperfusion injury. Adv Pharmacol Sci 2011, 2011:976951.
11. Dejana E. Endothelial cell-cell junctions: happy together. Nat Rev Mol Cell Biol 2004, 5:261-270.
12. Dubal D.B., Shughrue P.J., Wilson M.E., Merchenthaler I., Wise P.M. Estradiol modulates bcl-2 in cerebral ischemia: a potential role for estrogen receptors. J Neurosci 1999, 19:6385-6393.
13. Dubal D.B., Zhu H., Yu J., Rau S.W., Shughrue P.J., Merchenthaler I., Kindy M.S., Wise P.M. Estrogen receptor alpha, not beta, is a critical link in estradiol-mediated protection against brain injury. Proc Natl Acad Sci U S A 2001, 98:1952-1957.
14. Farr T.D., Carswell H.V., Gsell W., Macrae I.M. Estrogen receptor beta agonist diarylpropiolnitrile (DPN) does not mediate neuroprotection in a rat model of permanent focal ischemia. Brain Res 2007, 1185:275-282.
15. Handa R.J., Ogawa S., Wang J.M., Herbison A.E. Roles for oestrogen receptor beta in adult brain function. J Neuroendocrinol 2012, 24:160-173.
16. Hoffman G.E., Merchenthaler I., Zup S.L. Neuroprotection by ovarian hormones in animal models of neurological disease. Endocrine 2006, 29:217-231.
17. Jesmin S., Hattori Y., Sakuma I., Liu M.Y., Mowa C.N., Kitabatake A. Estrogen deprivation and replacement modulate cerebral capillary density with vascular expression of angiogenic molecules in middle-aged female rats. J Cereb Blood Flow Metab 2003, 23:181-189.
18. Johnson M.L., Ho C.C., Day A.E., Walker Q.D., Francis R., Kuhn C.M. Oestrogen receptors enhance dopamine neurone survival in rat midbrain. J Neuroendocrinol 2010, 22:226-237.
19. Kang H.S., Ahn H.S., Kang H.J., Gye M.C. Effect of estrogen on the expression of occludin in ovariectomized mouse brain. Neurosci Lett 2006, 402:30-34.
20. Kazi A.A., Jones J.M., Koos R.D. Chromatin immunoprecipitation analysis of gene expression in the rat uterus in vivo: estrogen-induced recruitment of both estrogen receptor alpha and hypoxia-inducible factor 1 to the vascular endothelial growth factor promoter. Mol Endocrinol 2005, 19:2006-2019.
21. Kobayashi H., Yanagita T., Yokoo H., Wada A. Molecular mechanisms and drug development in aquaporin water channel diseases: aquaporins in the brain. J Pharmacol Sci 2004, 96:264-270.
22. Leon R.L., Huber J.D., Rosen C.L. Potential age-dependent effects of estrogen on neural injury. Am J Pathol 2011, 178:2450-2460.
23. Lim W., Cho J., Kwon H.Y., Park Y., Rhyu M.R., Lee Y. Hypoxia-inducible factor 1 alpha activates and is inhibited by unoccupied estrogen receptor beta. FEBS Lett 2009, 583:1314-1318.
24. Lin T.N., He Y.Y., Wu G., Khan M., Hsu C.Y. Effect of brain edema on infarct volume in a focal cerebral ischemia model in rats. Stroke 1993, 24:117-121.
25. Liu F., Yuan R., Benashski S.E., McCullough L.D. Changes in experimental stroke outcome across the life span. J Cereb Blood Flow Metab 2009, 29:792-802.
26. Liu R., Wen Y., Perez E., Wang X., Day A.L., Simpkins J.W., Yang S.H. 17beta-Estradiol attenuates blood-brain barrier disruption induced by cerebral ischemia-reperfusion injury in female rats. Brain Res 2005, 1060:55-61.
27. Mak P., Leav I., Pursell B., Bae D., Yang X., Taglienti C.A., Gouvin L.M., Sharma V.M., Mercurio A.M. ERbeta impedes prostate cancer EMT by destabilizing HIF-1alpha and inhibiting VEGF-mediated snail nuclear localization: implications for Gleason grading. Cancer Cell 2010, 17:319-332.
28. Marin R., Guerra B., Alonso R., Ramirez C.M., Diaz M. Estrogen activates classical and alternative mechanisms to orchestrate neuroprotection. Curr Neurovasc Res 2005, 2:287-301.
29. Miller N.R., Jover T., Cohen H.W., Zukin R.S., Etgen A.M. Estrogen can act via estrogen receptor alpha and beta to protect hippocampal neurons against global ischemia-induced cell death. Endocrinology 2005, 146:3070-3079.
30. Mitra S.W., Hoskin E., Yudkovitz J., Pear L., Wilkinson H.A., Hayashi S., Pfaff D.W., Ogawa S., Rohrer S.P., Schaeffer J.M., McEwen B.S., Alves S.E. Immunolocalization of estrogen receptor beta in the mouse brain: comparison with estrogen receptor alpha. Endocrinology 2003, 144:2055-2067.
31. Morani A., Barros R.P., Imamov O., Hultenby K., Arner A., Warner M., Gustafsson J.A. Lung dysfunction causes systemic hypoxia in estrogen receptor beta knockout (ERbeta-/-) mice. Proc Natl Acad Sci U S A 2006, 103:7165-7169.
32. Mu D., Jiang X., Sheldon R.A., Fox C.K., Hamrick S.E., Vexler Z.S., Ferriero D.M. Regulation of hypoxia-inducible factor 1alpha and induction of vascular endothelial growth factor in a rat neonatal stroke model. Neurobiol Dis 2003, 14:524-534.
33. Nilsson S., Koehler K.F., Gustafsson J.A. Development of subtype-selective oestrogen receptor-based therapeutics. Nat Rev Drug Discov 2011, 10:778-792.
34. Noppens R.R., Kofler J., Grafe M.R., Hurn P.D., Traystman R.J. Estradiol after cardiac arrest and cardiopulmonary resuscitation is neuroprotective and mediated through estrogen receptor-beta. J Cereb Blood Flow Metab 2009, 29:277-286.
35. Persidsky Y., Ramirez S.H., Haorah J., Kanmogne G.D. Blood-brain barrier: structural components and function under physiologic and pathologic conditions. J Neuroimmune Pharmacol 2006, 1:223-236.
36. Rockwell L.C., Pillai S., Olson C.E., Koos R.D. Inhibition of vascular endothelial growth factor/vascular permeability factor action blocks estrogen-induced uterine edema and implantation in rodents. Biol Reprod 2002, 67:1804-1810.
37. Sandoval K.E., Witt K.A. Blood-brain barrier tight junction permeability and ischemic stroke. Neurobiol Dis 2008, 32:200-219.
38. Sandoval K.E., Witt K.A. Age and 17beta-estradiol effects on blood-brain barrier tight junction and estrogen receptor proteins in ovariectomized rats. Microvasc Res 2011, 81:198-205.
39. Sawada M., Alkayed N.J., Goto S., Crain B.J., Traystman R.J., Shaivitz A., Nelson R.J., Hurn P.D. Estrogen receptor antagonist ICI182,780 exacerbates ischemic injury in female mouse. J Cereb Blood Flow Metab 2000, 20:112-118.
40. Shi J., Bui J.D., Yang S.H., He Z., Lucas T.H., Buckley D.L., Blackband S.J., King M.A., Day A.L., Simpkins J.W. Estrogens decrease reperfusion-associated cortical ischemic damage: an MRI analysis in a transient focal ischemia model. Stroke 2001, 32:987-992.
41. Shin J.A., Choi J.H., Choi Y.H., Park E.M. Conserved aquaporin 4 levels associated with reduction of brain edema are mediated by estrogen in the ischemic brain after experimental stroke. Biochim Biophys Acta 2011, 1812:1154-1163.
42. Shin J.A., Park E.M., Choi J.S., Seo S.M., Kang J.L., Lee K.E., Cho S. Ischemic preconditioning-induced neuroprotection is associated with differential expression of IL-1beta and IL-1 receptor antagonist in the ischemic cortex. J Neuroimmunol 2009, 217:14-19.
43. Shughrue P.J., Lane M.V., Merchenthaler I. Comparative distribution of estrogen receptor-alpha and -beta mRNA in the rat central nervous system. J Comp Neurol 1997, 388:507-525.
44. Sibug R.M., Helmerhorst F.M., Tijssen A.M., de Kloet E.R., de Koning J. Estrogen reduces vascular endothelial growth factor(164) expression in the mouse nucleus paraventricularis of the hypothalamus. Neurosci Lett 2002, 333:199-202.
45. Strom J.O., Theodorsson A., Theodorsson E. Mechanisms of estrogens' dose-dependent neuroprotective and neurodamaging effects in experimental models of cerebral ischemia. Int J Mol Sci 2011, 12:1533-1562.
46. Swedenborg E., Power K.A., Cai W., Pongratz I., Ruegg J. Regulation of estrogen receptor beta activity and implications in health and disease. Cell Mol Life Sci 2009, 66:3873-3894.
47. van Bruggen N., Thibodeaux H., Palmer J.T., Lee W.P., Fu L., Cairns B., Tumas D., Gerlai R., Williams S.P., Campagne van Lookeren M., Ferrara N. VEGF antagonism reduces edema formation and tissue damage after ischemia/reperfusion injury in the mouse brain. J Clin Invest 1999, 104:1613-1620.
48. Yang Y., Estrada E.Y., Thompson J.F., Liu W., Rosenberg G.A. Matrix metalloproteinase-mediated disruption of tight junction proteins in cerebral vessels is reversed by synthetic matrix metalloproteinase inhibitor in focal ischemia in rat. J Cereb Blood Flow Metab 2007, 27:697-709.
49. Yeh S.H., Ou L.C., Gean P.W., Hung J.J., Chang W.C. Selective inhibition of early - but not late - expressed HIF-1alpha is neuroprotective in rats after focal ischemic brain damage. Brain Pathol 2011, 21:249-262.
50. Zhang Z.G., Zhang L., Jiang Q., Zhang R., Davies K., Powers C., Bruggen N., Chopp M. VEGF enhances angiogenesis and promotes blood-brain barrier leakage in the ischemic brain. J Clin Invest 2000, 106:829-838.